AR022723A1 - Compuestos analgesicos que comprenden compuestos antiepilepticos y metodos para usarlas - Google Patents
Compuestos analgesicos que comprenden compuestos antiepilepticos y metodos para usarlasInfo
- Publication number
- AR022723A1 AR022723A1 ARP000100763A ARP000100763A AR022723A1 AR 022723 A1 AR022723 A1 AR 022723A1 AR P000100763 A ARP000100763 A AR P000100763A AR P000100763 A ARP000100763 A AR P000100763A AR 022723 A1 AR022723 A1 AR 022723A1
- Authority
- AR
- Argentina
- Prior art keywords
- compounds
- combinations
- pain
- methods
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Combinaciones de compuestos antiepilépticos que demuestran propiedades para aliviar el dolor, con compuestos seleccionados del grupo que consiste en analgésicos, antagonistas del receptor de NMDA, NSAID y combinaciones de las mismas, y composiciones farmacéuticas que las comprenden. La administración de compuestos antiepilépticos que demuestran propiedades que alivian el dolor en estas combinaciones da como resultado una reducción mejorada en la frecuencia y severidad del dolor. Las combinaciones pueden reducir la incidencia de efectos colaterales no deseados en comparación con el uso de dosis más elevadas de un tratamiento de un solo agente para lograr un efecto terapéutico similar. Métodos para usar cantidades efectivas de las composiciones farmacéuticas para tratar el dolor en mamíferos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12373999P | 1999-03-10 | 1999-03-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR022723A1 true AR022723A1 (es) | 2002-09-04 |
Family
ID=22410582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000100763A AR022723A1 (es) | 1999-03-10 | 2000-02-23 | Compuestos analgesicos que comprenden compuestos antiepilepticos y metodos para usarlas |
Country Status (11)
Country | Link |
---|---|
US (1) | US6451857B1 (es) |
EP (1) | EP1161263A1 (es) |
JP (1) | JP2002538221A (es) |
AR (1) | AR022723A1 (es) |
AU (1) | AU3216600A (es) |
BR (1) | BR0008847A (es) |
CA (1) | CA2359485A1 (es) |
CO (1) | CO5150189A1 (es) |
PE (1) | PE20001558A1 (es) |
UY (1) | UY26052A1 (es) |
WO (1) | WO2000053225A1 (es) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1094757C (zh) | 1996-07-24 | 2002-11-27 | 沃尼尔·朗伯公司 | 用于治疗疼痛的异丁基γ-氨基丁酸及其衍生物 |
US6593368B2 (en) | 1997-09-08 | 2003-07-15 | Warner-Lambert Company | Analgesic compositions comprising anti-epileptic compounds and methods of using same |
ES2255500T3 (es) * | 1999-07-02 | 2006-07-01 | Warner-Lambert Company Llc | Combinacion simergica. gabapentina y pregabalina. |
ZA200108038B (en) * | 2000-10-02 | 2003-04-01 | Pfizer Prod Inc | Prophylactic use of n-methyl-d-asparrate (NMDA) antagonists. |
PT2266558T (pt) | 2001-06-07 | 2017-07-21 | Analgesic Neuropharmaceuticals Llc | Tratamento da dor neuropática com o antagonista dos recetores de n-metil-d-aspartato (nmda) dextrometorfano |
AU2002333374B2 (en) | 2001-09-03 | 2007-03-22 | Newron Pharmaceuticals S.P.A. | Pharmaceutical composition comprising gabapentin or an analogue thereof and an (alpha)- aminoamide and its analgesic use |
US7612112B2 (en) | 2001-10-25 | 2009-11-03 | Depomed, Inc. | Methods of treatment using a gastric retained gabapentin dosage |
TWI312285B (en) | 2001-10-25 | 2009-07-21 | Depomed Inc | Methods of treatment using a gastric retained gabapentin dosage |
US6730667B2 (en) * | 2001-11-26 | 2004-05-04 | William R. Deagle | Iontophoresis disc pain blocker |
US20060167032A1 (en) * | 2002-01-16 | 2006-07-27 | Galer Bradley S | Pharmaceutical composition and method for treating disorders of the central nervous system |
JP4428053B2 (ja) * | 2002-02-05 | 2010-03-10 | 味の素株式会社 | ガバペンチン若しくはプレガバリンおよびn型カルシウムチャンネル拮抗剤を含有する医薬組成物 |
JP2005523281A (ja) * | 2002-02-22 | 2005-08-04 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | アルファ−2−デルタリガンドとシクロオキシゲナーゼ−2の選択的阻害剤との組合せ |
US20050089559A1 (en) * | 2003-10-23 | 2005-04-28 | Istvan Szelenyi | Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains |
FR2862875B1 (fr) * | 2003-12-02 | 2006-04-07 | Mathey Acoustique Service | Preparation pharmaceutique pour le traitement des acouphenes |
WO2005102390A2 (en) * | 2004-04-22 | 2005-11-03 | Pfizer Japan, Inc. | Combinations comprising alpha-2-delta ligands and nmda receptor antagonists |
RS54522B1 (en) | 2005-12-22 | 2016-06-30 | Newron Pharmaceuticals S.P.A. | 2-Phenylethylamino Derivatives as Modulators of Calcium and (or Sodium) Channels |
US20090176882A1 (en) | 2008-12-09 | 2009-07-09 | Depomed, Inc. | Gastric retentive gabapentin dosage forms and methods for using same |
US7960436B2 (en) * | 2006-06-05 | 2011-06-14 | Valeant Pharmaceuticals International | Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators |
CA2661462C (en) * | 2006-08-23 | 2015-09-29 | Valeant Pharmaceuticals International | Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators |
US8993593B2 (en) * | 2006-08-23 | 2015-03-31 | Valeant Pharmaceuticals International | N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators |
US8722929B2 (en) * | 2006-10-10 | 2014-05-13 | Valeant Pharmaceuticals International | N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators |
JP2010511052A (ja) * | 2006-11-28 | 2010-04-08 | バレアント ファーマシューティカルズ インターナショナル | カリウムチャネル調節因子としての1,4ジアミノ二環式レチガビンアナログ |
RS51940B (en) * | 2006-12-22 | 2012-02-29 | Recordati Ireland Limited | Combined TH2δ LIGANAD THERAPY AND NSAID FOR LOWER URINARY TRACT DISORDERS |
US8367684B2 (en) * | 2007-06-13 | 2013-02-05 | Valeant Pharmaceuticals International | Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators |
US8563566B2 (en) * | 2007-08-01 | 2013-10-22 | Valeant Pharmaceuticals International | Naphthyridine derivatives as potassium channel modulators |
US7786146B2 (en) * | 2007-08-13 | 2010-08-31 | Valeant Pharmaceuticals International | Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
EP2116539A1 (en) | 2008-04-25 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof |
JP2010043063A (ja) | 2008-05-09 | 2010-02-25 | Agency For Science Technology & Research | 川崎病の診断及び治療 |
US20100190752A1 (en) | 2008-09-05 | 2010-07-29 | Gruenenthal Gmbh | Pharmaceutical Combination |
AU2009296457A1 (en) | 2008-09-27 | 2010-04-01 | Taraxos Inc. | Topical formulations for treatment of neuropathy |
CN102216257B (zh) | 2008-10-08 | 2015-11-25 | 凯飞药业公司 | Gaba偶联物及其使用方法 |
TN2016000228A1 (en) | 2013-12-17 | 2017-10-06 | Esteve Labor Dr | SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs) AND SIGMA RECEPTOR LIGANDS COMBINATIONS. |
TN2016000229A1 (en) * | 2013-12-17 | 2017-10-06 | Esteve Labor Dr | Gabapentinoids and sigma receptor ligands combinations. |
BR112016028924A2 (pt) | 2014-06-16 | 2017-08-22 | Farm Rayere S A | composição farmacêutica que combina um anticonvulsivante e um derivado de ácido nicotínico |
MX2015016589A (es) | 2015-12-02 | 2017-06-01 | Samuel CHAIT AUERBACH Jaime | Composicion oral veterinaria con gabapentina. |
WO2017177160A1 (en) * | 2016-04-07 | 2017-10-12 | Nevakar Llc | Formulation for use in a method of treatment of pain |
WO2017200700A1 (en) * | 2016-05-16 | 2017-11-23 | PixarBio Corporation | Methods for treating incisional pain |
EP3687520A4 (en) * | 2017-09-28 | 2021-06-23 | Nevakar, Inc | FIXED-DOSE COMBINATION FORMULATIONS FOR THE TREATMENT OF PAIN |
EP3691748A4 (en) | 2017-10-03 | 2021-07-07 | Nevakar, Inc | ACETAMINOPHEN-PREGABALIN COMBINATIONS AND METHODS OF TREATMENT OF PAIN |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4694010A (en) * | 1985-08-16 | 1987-09-15 | New York University | Anticonvulsant compositions and method |
CA2264182A1 (en) | 1996-08-23 | 1998-02-26 | Algos Pharmaceutical Corporation | Anticonvulsant containing composition for treating neuropathic pain |
WO1999008670A1 (en) | 1997-08-20 | 1999-02-25 | Guglietta, Antonio | Gaba analogs to prevent and treat gastrointestinal damage |
US6593368B2 (en) | 1997-09-08 | 2003-07-15 | Warner-Lambert Company | Analgesic compositions comprising anti-epileptic compounds and methods of using same |
-
2000
- 2000-01-27 US US09/936,394 patent/US6451857B1/en not_active Expired - Fee Related
- 2000-01-27 JP JP2000603714A patent/JP2002538221A/ja not_active Withdrawn
- 2000-01-27 WO PCT/US2000/002080 patent/WO2000053225A1/en not_active Application Discontinuation
- 2000-01-27 EP EP00909998A patent/EP1161263A1/en not_active Ceased
- 2000-01-27 CA CA002359485A patent/CA2359485A1/en not_active Abandoned
- 2000-01-27 AU AU32166/00A patent/AU3216600A/en not_active Abandoned
- 2000-01-27 BR BR0008847-1A patent/BR0008847A/pt not_active IP Right Cessation
- 2000-02-23 AR ARP000100763A patent/AR022723A1/es unknown
- 2000-03-08 CO CO00016924A patent/CO5150189A1/es unknown
- 2000-03-08 UY UY26052A patent/UY26052A1/es not_active Application Discontinuation
- 2000-03-08 PE PE2000000204A patent/PE20001558A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2000053225A1 (en) | 2000-09-14 |
AU3216600A (en) | 2000-09-28 |
UY26052A1 (es) | 2000-08-21 |
US6451857B1 (en) | 2002-09-17 |
CO5150189A1 (es) | 2002-04-29 |
CA2359485A1 (en) | 2000-09-14 |
BR0008847A (pt) | 2001-12-26 |
EP1161263A1 (en) | 2001-12-12 |
JP2002538221A (ja) | 2002-11-12 |
PE20001558A1 (es) | 2001-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR022723A1 (es) | Compuestos analgesicos que comprenden compuestos antiepilepticos y metodos para usarlas | |
NO20001175L (no) | Smertestillende blandinger omfattende anti-epileptiske forbindelser og fremgangsmõter for anvendelse derav | |
PA8515001A1 (es) | Una composicion farmaceutica para el tratamiento del dolor agudo, cronico y/o el dolor neuropatico y las migrañas | |
BR9909903A (pt) | Eficácia máxima de substâncias usadas para melhorar a saúde e bem-estar | |
CL2004000452A1 (es) | Uso de un compuesto antiepileptico que contiene propiedades de alivio del dolor y dos o mas compuestos del grupo formado por antagonista del nmda selectivos de subtipo, analgesicos, nsaid, y combinaciones de ellos, para la preparacion de un medicamen | |
AR060836A1 (es) | Un disco trans-mucosa para administrar un agente activo, una composicion trans-mucosa y el metodo de administracion obtenido | |
AR074313A1 (es) | Metodo para tratar o prevenir la trombosis utilizando etexilato de dabigatran o una sal del mismo. uso. kit | |
Segraws | Antidepressant-induced orgasm disorder | |
SV2006002256A (es) | Uso de un anticuerpo para tratar la vasculitis | |
BR0111207A (pt) | Combinações de um antagonista receptor de endotelina e um composto antiepiléptico tendo propriedades de alìvio da dor ou analgésicos | |
NO990912L (no) | Terapeutiske kombinasjoner av PAR-antagonister og RXR-agonister og bruken derav | |
AR040248A1 (es) | Farmaco para el tratamiento de la vejiga hiperactiva | |
AR047719A1 (es) | Procedimiento para el tratamiento de trastornos de depresion y ansiedad mediante terapia de combinacion que comprenden un ligando alfa-2-delta y un ssri y/o un snri | |
EA200600817A1 (ru) | Антагонисты в1 рецептора брадикинина (варианты), фармацевтическая композиция, лекарственное средство, способ лечения заболеваний (варианты) | |
AR045783A1 (es) | Composición farmacéutica que comprende un antagonista del receptor p2x7 y una droga anti-inflamatoria no esteroide | |
AR052830A1 (es) | Regimen de cladribina para tratar esclerosis multiple | |
CO5160295A1 (es) | Nuevas combinaciones farmaceuticas para inhibidores de la nos cionalmente un ssri | |
AR027394A1 (es) | Uso de mirtazapina para el tratamiento de trastornos del sueno | |
ECSP003378A (es) | Composiciones analgesicas que comprenden compuestos antiepilepticos y metodos para usarlas | |
DE60004833D1 (de) | Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung | |
AR027677A1 (es) | Una composicion farmaceutica terapeutica que comprende camptotecina y ciclofosfamida para el tratamiento del cancer | |
AR061046A1 (es) | Mirtazapina para el tratamiento del dolor neuropatico | |
Okulicz-Kozaryn et al. | The effects of midazolam and morphine on analgesic and sedative activity of ketamine in rats | |
Liedtke | Pharmacological concept for topical synergistic analgesia of peripheral neuromuscular pain | |
EA200100223A2 (ru) | Воднодисперсная лекарственная форма ивермектина для лечения экто- и эндопаразитозов |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |